Target Price | $163.20 |
Price | $153.81 |
Potential | 6.10% |
Number of Estimates | 18 |
18 Analysts have issued a price target 3M 2026 . The average 3M target price is $163.20. This is 6.10% higher than the current stock price. The highest price target is $193.20 25.61% , the lowest is $101.00 34.33% . | |
A rating was issued by 23 analysts: 15 Analysts recommend 3M to buy, 6 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the 3M stock has an average upside potential 2026 of 6.10% . Most analysts recommend the 3M stock at Purchase. |
21 Analysts have issued a sales forecast 3M 2025 . The average 3M sales estimate is $24.2b . This is 1.37% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $25.6b 4.46% , the lowest is $23.1b 5.65% .
This results in the following potential growth metrics:
2024 | $24.6b | 0.14% |
---|---|---|
2025 | $24.2b | 1.62% |
2026 | $24.9b | 2.99% |
2027 | $25.7b | 3.32% |
2028 | $27.0b | 4.82% |
2029 | $28.3b | 5.07% |
19 Analysts have issued an 3M EBITDA forecast 2025. The average 3M EBITDA estimate is $6.7b . This is 7.93% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.2b 16.11% , the lowest is $6.3b 1.12% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $6.4b | 3.16% |
---|---|---|
2025 | $6.7b | 5.68% |
2026 | $7.2b | 6.74% |
2027 | $7.7b | 7.12% |
2028 | $7.3b | 5.34% |
2029 | $8.2b | 11.87% |
2024 | 25.93% | 3.30% |
---|---|---|
2025 | 27.85% | 7.41% |
2026 | 28.87% | 3.66% |
2027 | 29.93% | 3.67% |
2028 | 27.03% | 9.69% |
2029 | 28.78% | 6.47% |
21 3M Analysts have issued a net profit forecast 2025. The average 3M net profit estimate is $4.2b . This is 4.32% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $4.5b 3.66% , the lowest is $3.9b 9.90% .
This results in the following potential growth metrics and future Net Margins:
2024 | $4.2b | 159.66% |
---|---|---|
2025 | $4.2b | 0.01% |
2026 | $4.5b | 8.56% |
2027 | $5.0b | 9.99% |
2028 | $5.1b | 3.31% |
2029 | $5.4b | 4.96% |
2024 | 16.98% | 159.74% |
---|---|---|
2025 | 17.26% | 1.64% |
2026 | 18.19% | 5.39% |
2027 | 19.37% | 6.49% |
2028 | 19.09% | 1.45% |
2029 | 19.07% | 0.10% |
21 Analysts have issued a 3M forecast for earnings per share. The average 3M EPS is $7.75 . This is 2.64% lower than earnings per share in the financial year 2024. The highest EPS forecast is $8.40 5.53% , the lowest is $7.30 8.29% .
This results in the following potential growth metrics and future valuations:
2024 | $7.55 | 159.83% |
---|---|---|
2025 | $7.75 | 2.65% |
2026 | $8.42 | 8.65% |
2027 | $9.26 | 9.98% |
2028 | $9.56 | 3.24% |
2029 | $10.04 | 5.02% |
Current | 19.13 | 337.32% |
---|---|---|
2025 | 19.64 | 2.69% |
2026 | 18.09 | 7.89% |
2027 | 16.44 | 9.12% |
2028 | 15.92 | 3.16% |
2029 | 15.16 | 4.77% |
Based on analysts' sales estimates for 2025, the 3M stock is valued at an EV/Sales of 3.66 and an P/S ratio of 3.39 .
This results in the following potential growth metrics and future valuations:
Current | 3.61 | 65.60% |
---|---|---|
2025 | 3.66 | 1.27% |
2026 | 3.55 | 2.90% |
2027 | 3.44 | 3.21% |
2028 | 3.28 | 4.59% |
2029 | 3.12 | 4.82% |
Current | 3.34 | 81.26% |
---|---|---|
2025 | 3.39 | 1.39% |
2026 | 3.29 | 2.90% |
2027 | 3.18 | 3.22% |
2028 | 3.04 | 4.59% |
2029 | 2.89 | 4.82% |
Analyst | Rating | Action | Date |
---|---|---|---|
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jul 01 2025 |
Citigroup |
Neutral
➜
Neutral
|
Unchanged | May 30 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | May 16 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 23 2025 |
RBC Capital |
Underperform
➜
Underperform
|
Unchanged | Apr 23 2025 |
Citigroup |
Neutral
➜
Neutral
|
Unchanged | Apr 14 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 10 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jul 01 2025 |
Unchanged
Citigroup:
Neutral
➜
Neutral
|
May 30 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
May 16 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 23 2025 |
Unchanged
RBC Capital:
Underperform
➜
Underperform
|
Apr 23 2025 |
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Apr 14 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.